Platelet-Rich Plasma

Platelet-rich plasma (PRP) is an autologous blood-derived product characterized by a concentration of platelets that is at least two to three times higher than normal levels. Researchers primarily study PRP for its potential regenerative effects and therapeutic applications across various medical fields, including orthopedics, dermatology, and sports medicine. Key findings from the literature indicate that PRP may promote cellular proliferation, enhance tissue regeneration, and modulate inflammation, with clinical evidence suggesting its efficacy in managing conditions such as osteoarthritis and skin rejuvenation. Despite ongoing debates regarding its effectiveness in certain applications, the popularity of PRP therapy continues to grow, with researchers actively exploring new indications and refining treatment protocols. Current studies aim to standardize PRP preparation and application methods to maximize its clinical relevance and therapeutic outcomes.

Platelet-rich plasma (PRP) is an autologous blood-derived product that contains a concentration of platelets significantly higher than baseline levels. It is produced from the patient's own blood through a process of centrifugation, which isolates the plasma fraction rich in platelets. PRP is categorized under growth factors due to its high content of platelet-related growth factors. Researchers have explored PRP's roles in various medical fields, particularly in regenerative medicine. It is used in the treatment of musculoskeletal conditions, dermatological applications such as hair restoration and skin rejuvenation, and in surgical procedures including maxillofacial and plastic surgery. The primary physiological roles of PRP involve promoting healing and tissue regeneration, leveraging its growth factors to enhance cellular proliferation, matrix formation, and angiogenesis. Researchers have observed that PRP acts through pathways involving cellular proliferation, inflammation regulation, and collagen synthesis, contributing to tissue remodeling and healing. The pharmacokinetic properties of PRP are not well-documented due to its autologous nature and localized application, making it challenging to define parameters such as half-life or systemic metabolism. Clinically, PRP is used in a variety of medical and aesthetic procedures, with ongoing research into its efficacy and safety. Regulatory standing varies by region, with PRP often considered a medical procedure rather than a drug, thus not requiring traditional drug approval processes.

PRP acts by releasing growth factors that bind to cell surface receptors, initiating a cascade of biological processes including cellular proliferation, angiogenesis, and collagen synthesis. These pathways contribute to tissue regeneration and healing, with additional effects on inflammation modulation and matrix formation.

Platelet-rich plasma (PRP) exerts its effects primarily through the activation of platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-β) receptors, which initiate signaling pathways such as the phosphoinositide 3-kinase (PI3K)/Akt pathway and the mitogen-activated protein kinase (MAPK) pathway. These pathways promote cellular proliferation, angiogenesis, collagen synthesis, and tissue remodeling. Although the precise mechanisms remain incompletely understood, PRP is also known to modulate inflammation and enhance wound healing through various growth factors and cytokines released from activated platelets.

Current evidence is limited regarding the optimal treatment protocols for PRP across various medical fields, particularly in dermatology and orthopedics, where standardization is crucial for consistent outcomes. Further research is needed to resolve conflicting findings related to PRP's efficacy in treating specific conditions, such as tendinopathies and osteoarthritis in less-studied joints, and to establish larger randomized controlled trials (RCTs) that include diverse populations and long-term follow-up data to assess the durability of treatment effects. Additionally, the underlying cellular and molecular mechanisms of PRP's action in different therapeutic contexts remain inadequately explored, necessitating studies that investigate these pathways in detail.